# Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

> **NCT00947037** · PHASE2 · WITHDRAWN · sponsor: **Intec Pharma Ltd.**

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** AP-CD/LD

## Key facts

- **NCT ID:** NCT00947037
- **Lead sponsor:** Intec Pharma Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-08
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The sponsor decided to postpone the performance of this study to after phase 3
- **Last updated:** 2015-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947037, "Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00947037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*